Cargando…
Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
BACKGROUND: NUDT15 and TPMT variants are strong genetic determinants of thiopurine-induced hematological toxicity that results in therapeutic failure in pediatric acute lymphoblastic leukemia (ALL). However, many patients with both wild-type (WT) NUDT15 and TPMT still suffer from thiopurine toxicity...
Autores principales: | Park, Yoomi, Kim, Hyery, Seo, Heewon, Choi, Jung Yoon, Ma, Youngeun, Yun, Sunmin, Min, Byung-Joo, Seo, Myung-Eui, Yoo, Keon Hee, Kang, Hyoung Jin, Im, Ho Joon, Kim, Ju Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328279/ https://www.ncbi.nlm.nih.gov/pubmed/32611418 http://dx.doi.org/10.1186/s12967-020-02416-7 |
Ejemplares similares
-
Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT
por: Kim, Hyery, et al.
Publicado: (2021) -
Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia
por: Correa-Jimenez, Oscar, et al.
Publicado: (2021) -
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
por: Goh, Liuh Ling, et al.
Publicado: (2022) -
TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
por: Grover, Narinder, et al.
Publicado: (2021) -
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011)